• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.08% Nasdaq Up0.95%

    Cortex Pharmaceuticals, Inc. (CORX)

    -Other OTC
    0.02 Down 0.00(5.00%) 3:09PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 62   -   48  
    Cost of Revenue -   -   -  
    Gross Profit 62   -   48  
    Operating Expenses
    Research Development592  207  827  
    Selling General and Administrative3,823  933  1,986  
    Non Recurring -   -  4,568  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (4,354) (1,140) (7,332)
    Income from Continuing Operations
    Total Other Income/Expenses Net1,763  (5)(43)
    Earnings Before Interest And Taxes(2,590)(1,145)(7,375)
    Interest Expense117  56  197  
    Income Before Tax(2,708)(1,201)(7,572)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(2,708)(1,201)(7,572)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (2,708) (1,201) (7,572)
    Preferred Stock And Other Adjustments(10,061) -   -  
    Net Income Applicable To Common Shares (12,768) (1,201) (7,572)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.